Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
PDLI similar filings
- 12 Jul 12 Regulation FD Disclosure
- 19 Jun 12 PDL to Receive Royalties on Sales of Genentech’s Pertuzumab
- 15 Jun 12 PDL BioPharma Completes Regular Quarterly Dividend Payment
- 14 Jun 12 Regulation FD Disclosure
- 13 Jun 12 PDL BioPharma Provides Second Quarter 2012 Royalty Revenue Guidance of $125 Million
- 6 Jun 12 Regulation FD Disclosure
- 6 Jun 12 Submission of Matters to a Vote of Security Holders
Filing view
External links
Exhibit 99.1
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide1.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide2.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide3.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide4.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide5.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide6.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide7.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide8.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide9.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide10.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide11.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide12.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide13.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide14.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide15.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide16.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide17.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide18.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide19.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide20.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide21.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide22.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide23.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide24.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide25.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide26.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide27.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide28.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide29.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide30.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide31.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide32.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide33.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide34.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide35.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-006109/slide36.jpg)